Carcinoma, Ductal  >>  aldoxorubicin (INNO-206)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
aldoxorubicin (INNO-206) / LadRx
NCT01580397: Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer

Completed
2
15
US
INNO-206, Aldoxorubicin
ImmunityBio, Inc.
Pancreatic Ductal Adenocarcinoma
05/13
07/13

Download Options